Logo image of ALMCE.PA

MON COURTIER ENERGIE GROUPE (ALMCE.PA) Stock Fundamental Analysis

Europe - EPA:ALMCE - FR001400H3A0 - Common Stock

5.65 EUR
0 (0%)
Last: 10/22/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALMCE scores 4 out of 10 in our fundamental rating. ALMCE was compared to 19 industry peers in the Independent Power and Renewable Electricity Producers industry. ALMCE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALMCE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALMCE had negative earnings in the past year.
In the past year ALMCE had a positive cash flow from operations.
ALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.10%, ALMCE is doing worse than 68.42% of the companies in the same industry.
ALMCE has a Return On Equity of -2.30%. This is in the lower half of the industry: ALMCE underperforms 63.16% of its industry peers.
Industry RankSector Rank
ROA -1.1%
ROE -2.3%
ROIC N/A
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMCE.PA Yearly ROA, ROE, ROICALMCE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

ALMCE's Gross Margin of 26.46% is in line compared to the rest of the industry. ALMCE outperforms 47.37% of its industry peers.
In the last couple of years the Gross Margin of ALMCE has remained more or less at the same level.
ALMCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
ALMCE.PA Yearly Profit, Operating, Gross MarginsALMCE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

ALMCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALMCE remains at a similar level compared to 1 year ago.
The debt/assets ratio for ALMCE is higher compared to a year ago.
ALMCE.PA Yearly Shares OutstandingALMCE.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
ALMCE.PA Yearly Total Debt VS Total AssetsALMCE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 2.81 indicates that ALMCE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ALMCE (2.81) is better than 73.68% of its industry peers.
ALMCE has a debt to FCF ratio of 2.76. This is a good value and a sign of high solvency as ALMCE would need 2.76 years to pay back of all of its debts.
ALMCE has a better Debt to FCF ratio (2.76) than 100.00% of its industry peers.
ALMCE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
ALMCE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. ALMCE outperforms 94.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Altman-Z 2.81
ROIC/WACCN/A
WACC8.03%
ALMCE.PA Yearly LT Debt VS Equity VS FCFALMCE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.80 indicates that ALMCE should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.80, ALMCE is doing good in the industry, outperforming 63.16% of the companies in the same industry.
ALMCE has a Quick Ratio of 1.80. This is a normal value and indicates that ALMCE is financially healthy and should not expect problems in meeting its short term obligations.
ALMCE has a better Quick ratio (1.80) than 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.8
ALMCE.PA Yearly Current Assets VS Current LiabilitesALMCE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

6

3. Growth

3.1 Past

The earnings per share for ALMCE have decreased strongly by -117.71% in the last year.
ALMCE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.25%.
The Revenue has been growing by 36.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-117.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.51%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%

3.2 Future

Based on estimates for the next years, ALMCE will show a very strong growth in Earnings Per Share. The EPS will grow by 55.85% on average per year.
Based on estimates for the next years, ALMCE will show a quite strong growth in Revenue. The Revenue will grow by 12.21% on average per year.
EPS Next Y221.43%
EPS Next 2Y94.57%
EPS Next 3Y55.85%
EPS Next 5YN/A
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMCE.PA Yearly Revenue VS EstimatesALMCE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALMCE.PA Yearly EPS VS EstimatesALMCE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

ALMCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 12.19, which indicates a correct valuation of ALMCE.
68.42% of the companies in the same industry are more expensive than ALMCE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, ALMCE is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.19
ALMCE.PA Price Earnings VS Forward Price EarningsALMCE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALMCE.
Based on the Price/Free Cash Flow ratio, ALMCE is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 67.36
EV/EBITDA 30.72
ALMCE.PA Per share dataALMCE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMCE's earnings are expected to grow with 55.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y94.57%
EPS Next 3Y55.85%

0

5. Dividend

5.1 Amount

No dividends for ALMCE!.
Industry RankSector Rank
Dividend Yield N/A

MON COURTIER ENERGIE GROUPE

EPA:ALMCE (10/22/2025, 7:00:00 PM)

5.65

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.68M
Revenue(TTM)24.67M
Net Income(TTM)-230000
Analysts84.44
Price Target6.94 (22.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP-530%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)542.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.19
P/S 0.84
P/FCF 67.36
P/OCF 29.17
P/B 2.07
P/tB 3.87
EV/EBITDA 30.72
EPS(TTM)-0.06
EYN/A
EPS(NY)0.46
Fwd EY8.2%
FCF(TTM)0.08
FCFY1.48%
OCF(TTM)0.19
OCFY3.43%
SpS6.74
BVpS2.73
TBVpS1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -2.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.46%
FCFM 1.24%
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Debt/EBITDA 0.01
Cap/Depr 80.72%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion 158.61%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.8
Altman-Z 2.81
F-Score5
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)39.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.73%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.51%
EPS Next Y221.43%
EPS Next 2Y94.57%
EPS Next 3Y55.85%
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A
EBIT growth 1Y-103.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year380%
EBIT Next 3Y75.44%
EBIT Next 5YN/A
FCF growth 1Y149.84%
FCF growth 3Y-48.05%
FCF growth 5YN/A
OCF growth 1Y231.05%
OCF growth 3Y-31.54%
OCF growth 5YN/A